A medical oncologist, Silvia Stacchiotti has a life-time professional dedication to patient care and research in bone and soft tissue sarcoma (STS), and gastrointestinal stromal tumor (GIST). She works in the Adult Mesenchymal and Rare Tumor Medical Treatment Unit, at the Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy, where she is involved in all institutional research activities on sarcoma, with a special focus on ultra-rare sarcomas. Her work focuses on the identification of new treatments for adult patients affected by sarcomas.
Over the last 20 years she has been working in collaboration with the worldwide sarcoma community and patient advocates to improve cure and care of selected sarcoma types through 1) studies on their natural history, sensitivity to conventional systemic agents, new targets, new anticancer agents and mechanisms of resistance; 2) consensus meetings to draft clinical guidelines on the best treatment approach to the disease; 3) promoting the interaction with the Agencies.
She is the president of the Italian Sarcoma Group, the Italian scientific society for sarcoma, the secretary of the Connective Tissue Oncology Society (CTOS), the secretary of the EORTC STBSG. She is the faculty coordinator of the Sarcoma group of the European Society for Medical Oncology (ESMO). She collaborates with several sarcoma Patient Advocacy Groups (PAG), among which the Chordoma Foundation, the Epithelioid Haemangioendothelioma Group, the Desmoid Tumor Research Foundation, in which she serves as a member of the corresponding medical advisory boards. She is the Principal Investigator of several trials on sarcoma. She has authored >250 scientific publications.
Silvia Stacchiotti received her medical degree in 1993, in Milan, and trained at INT. She is certified in Clinical Oncology. She has four children.
